Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 36.0B | 31.9B | 26.2B | 20.0B |
Cost of revenue | 8.6B | 7.9B | 6.5B | 5.0B |
Gross profit | 27.4B | 24.0B | 19.8B | 15.0B |
Operating expense | ||||
Research & development | 147.8M | 88.2M | 58.0M | 23.0M |
Selling general and admin | 4.2B | 3.4B | 3.6B | 3.3B |
Other operating expenses | 6.0B | 5.9B | 4.8B | 3.9B |
Operating income | 16.2B | 13.7B | 10.5B | 6.9B |
Non operating interest income | ||||
Income | 45.3M | 49.8M | 40.6M | 39.9M |
Expense | 33.7M | 39.7M | 1.0M | 992.4K |
Other income expense | — | — | — | — |
Pretax income | 16.5B | 14.2B | 10.9B | 7.1B |
Tax provision | 4.3B | 3.7B | 2.7B | 1.7B |
Net income | 12.3B | 10.5B | 8.2B | 5.4B |
Basic EPS | 10.0 | 8.6 | 6.6 | 4.4 |
Diluted EPS | 10.0 | 8.6 | 6.6 | 4.4 |
Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
EBITDA | 16.9B | 14.9B | 11.1B | 7.2B |
Net income from continuing op. | 12.3B | 10.5B | 8.2B | 5.4B |
Minority interests | -10.2M | -20.4M | -61.1M | -76.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |